| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9624 |
| Human Intestinal Absorption | HIA+ | 0.9923 |
| Caco-2 Permeability | Caco2+ | 0.6066 |
| P-glycoprotein Substrate | Non-substrate | 0.8364 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9822 |
| Non-inhibitor | 0.9849 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9473 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4810 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7332 |
| CYP450 2D6 Substrate | Non-substrate | 0.9515 |
| CYP450 3A4 Substrate | Non-substrate | 0.7887 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9227 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9526 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9707 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9816 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9748 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9839 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9700 |
| Non-inhibitor | 0.9893 |
| AMES Toxicity | Non AMES toxic | 0.9133 |
| Carcinogens | Carcinogens | 0.6536 |
| Fish Toxicity | High FHMT | 0.6484 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8311 |
| Honey Bee Toxicity | High HBT | 0.8227 |
| Biodegradation | Ready biodegradable | 0.8123 |
| Acute Oral Toxicity | III | 0.8675 |
| Carcinogenicity (Three-class) | Non-required | 0.7084 |